"Aminoquinolines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Quinolines substituted in any position by one or more amino groups.
| Descriptor ID |
D000634
|
| MeSH Number(s) |
D03.633.100.810.050
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Aminoquinolines".
Below are MeSH descriptors whose meaning is more specific than "Aminoquinolines".
This graph shows the total number of publications written about "Aminoquinolines" by people in this website by year, and whether "Aminoquinolines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2016 | 0 | 2 | 2 |
| 2017 | 4 | 3 | 7 |
| 2018 | 2 | 5 | 7 |
| 2019 | 3 | 1 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Aminoquinolines" by people in Profiles.
-
4-Aminoquinoline compounds from the Spanish flu to COVID-19. Biomed Pharmacother. 2021 Mar; 135:111138.
-
Assessment of effective imidazole derivatives against SARS-CoV-2 main protease through computational approach. Life Sci. 2020 Dec 01; 262:118469.
-
Potential therapeutic targets for combating SARS-CoV-2: Drug repurposing, clinical trials and recent advancements. Life Sci. 2020 Sep 01; 256:117883.
-
A systematic review on use of aminoquinolines for the therapeutic management of COVID-19: Efficacy, safety and clinical trials. Life Sci. 2020 Aug 01; 254:117775.
-
[Potential harms associated with 4-aminoquinoline treatment]. Lakartidningen. 2020 04 23; 117.
-
Facts and Myths: Efficacies of Repurposing Chloroquine and Hydroxychloroquine for the Treatment of COVID-19. Curr Drug Targets. 2020; 21(16):1703-1721.
-
[Eruptive epidermoid cysts after imiquimod treatment of recurrent basal cell carcinoma : A case report]. Hautarzt. 2019 May; 70(5):363-366.
-
Tafenoquine - A Radical Improvement? N Engl J Med. 2019 01 17; 380(3):285-286.
-
Single-Dose Tafenoquine to Prevent Relapse of Plasmodium vivax Malaria. N Engl J Med. 2019 01 17; 380(3):215-228.
-
Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria. N Engl J Med. 2019 01 17; 380(3):229-241.